Risk assessment and genetic testing for breast cancer are at the vanguard of a rapidly expanding field of medicine, while the molecular genetics of breast cancer is a focus for a growing field of basic and applied scientific research. The last decade has also seen an exponential rise in health 'activism' around breast cancer. Using an ethnographic approach, Sahra Gibbon examines the relationship between these seemingly parallel developments. She draws...